ASCIA Education Projects

In 2020-2021 ASCIA will focus on developing, updating and promoting the following educational resources and webpages:

ASCIA Telehealth resources | ASCIA COVID-19 resources | ASCIA Anaphylaxis projects | ASCIA Food Allergy projects | ASCIA Respiratory/Insect Allergy projects | ASCIA Drug (Medication) Allergy projectsASCIA Skin/Allergy projects | ASCIA Immunodeficiency projects    

ASCIA Telehealth resources 

The following recently completed resources will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020-2021:

  • New How Allergies Work animation (developed by the National Allergy Strategy)
  • New ASCIA Alllergy and the Immune System information for patients, consumers and carers

ASCIA COVID-19 resources 

The following recently completed resources will be promoted in 2020-2021:

ASCIA Anaphylaxis projects 

The following recently completed resources will be promoted in 2020-2021:

The following project is scheduled to be completed in 2020-2021:

  • New ASCIA Guide for Management of Anaphylaxis in Oncology Patients

ASCIA Food Allergy projects 

The following recently completed resources will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020-2021:

  • Updated ASCIA Food Allergy e-training and reference list (Completion is expected by late September 2020.
  • New ASCIA Cow's Milk Allergy Position Paper (for health professionals) - Completion is expected by late September 2020.
  • New Oral Allergy (Pollen Food) Syndrome patient information

ASCIA Respiratory/Insect Allergy projects 

The following recently completed resources will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020 (subject to funding):

  • Updated ASCIA Allergic Rhinitis e-training for health professionals
  • Updated ASCIA Allergic Rhinitis training slides 
  • New ASCIA Sublingual Immunotherapy (SLIT) treatment plan
  • Updated ASCIA Allergen Immunotherapy e-training for health professionals
  • Updated ASCIA Allergen Immunotherapy training slides 

ASCIA Drug (Medication) Allergy projects 

The following resources will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020-2021:

  • New ASCIA Cephalosporin Allergy consensus statement
  • Updated ASCIA Penicillin Allergy Consensus Statement
  • Updated ASCIA Penicillin Allergy Guide for health professionals
  • New ASCIA Drug Allergy Definitions
  • New ASCIA Drug Allergy Action Plan 
  • New ASCIA Drug Allergy Record

ASCIA Skin/Allergy projects 

The following resources will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020-2021 (subject to funding):

  • New ASCIA Atopic Dermatitis (Eczema) Clinical Update for health professionals (to include new immune modulating treatment options for severe eczema)
  • Updated ASCIA Eczema information for patients, consumers and carers www.allergy.org.au/patients/skin-allergy/eczema (to include new immune modulating treatment options for severe eczema)
  • Updated ASCIA Eczema Action Plan and Management Guide www.allergy.org.au/hp/ascia-plans-action-and-treatment#r4 (to include new immune modulating treatment options for severe eczema)

ASCIA Immunodeficiency projects 

The following will be promoted in 2020-2021:

The following projects are scheduled to be completed in 2020-2021:

© ASCIA August 2020             

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.